Work

PD-1 agonist modulates ILC2 metabolism and ameliorates airway hyperreactivity

Year: 2022

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.208.supp.109.15

Authors: Georges Doumet Helou, Pedram Shafiei-Jahani, Richard Lo, Emily Diane Howard, Benjamin P Hurrell, Lauriane Galle-Treger, Jacob Dean Painter, Gavin Lewis, Pejman Soroosh, Arlene H Sharpe, Omid Akbari

Institutions: University of Southern California, Janssen (Belgium), Janssen Research & Development (United States), Harvard University

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313430228

Cites:

Cited by:

Related to: 10